Dr. Steven H. Abman, MD is Professor of Pediatrics and Director of the Pediatric Heart Lung Center (PHLC) at the University of Colorado Denver Anschutz School of Medicine and Children’s Hospital Colorado. He obtained his undergraduate degree at Carleton College, attended Northwestern University Medical School, and completed his internship and residency in the Department of Pediatrics at the University of Colorado. After serving as Chief Resident, he completed a 3-year fellowship in Pediatric Pulmonary and Critical Care Medicine, joined the faculty of the University of Colorado in 1986, and was promoted to Professor in the tenure track in 1996.
Throughout his career, Dr. Abman has maintained strong translational research and clinical interests in neonatal lung injury, lung vascular development, pulmonary hypertension, chronic lung disease in the newborn (bronchopulmonary dysplasia, BPD), persistent pulmonary hypertension of the newborn (PPHN), and related areas. With outstanding collaborators in the PHLC and others, his lab explored many original basic and clinical studies on the physiology, pathobiology and treatment of pulmonary vascular disease in the newborn, which included early studies on nitric oxide (NO) biology and therapy in diverse experimental models and human preterm and term newborns. His lab continues to explore basic mechanisms through which early disruption of angiogenesis and “angiocrine signaling” during lung development impairs alveolarization and contributes to long-lasting abnormalities of lung structure, especially after preterm birth.
Dr. Abman’s interests in both clinical and laboratory research and patient care led to the launch the PHLC at Children’s Hospital Colorado, for which Dr. Abman has served as Director for nearly 25 years. The PHLC provides inter-disciplinary clinical care, research, training and education related to diverse pediatric cardiopulmonary disorders. Along with research training for many fellows and junior faculty, the PHLC has developed novel clinical care approaches that include development of the Pediatric Pulmonary Hypertension Program and Ventilator Care Program. More recently, Dr. Abman founded and continues to serve as Director of the Pediatric Pulmonary Hypertension Network (PPHNet), a multicenter clinical research and care group consisting of 10 leading PH centers from throughout North America, and initiated and led a joint American Heart Association/American Thoracic Society working group to establish the first joint guidelines for the care of children with pediatric pulmonary hypertension.
Dr. Abman has received several national awards, including the Outstanding Investigator Award from the American Academy of Pediatrics (1998), the E. Mead Johnson Award of the SPR (1999), and the Distinguished Achievement Award of the American Thoracic Society for outstanding contributions to fighting respiratory disease through research, education, patient care, and advocacy (2015). He was recently selected for the Mary Ellen Avery Award from the American Pediatric Society and Society for Pediatric Research “to recognize the lifetime achievement of a pediatric investigator who has made important contributions to neonatal health through basic or translational research” to be presented at the Pediatric Academic Societies Meeting, Baltimore, MD, Spring, 2016.
Dr. Abman has been active as an educator and research mentor for numerous trainees, which was recognized by the Career Teachers Scholar Award (2012) from the University of Colorado and the Maureen Andrews Mentorship Award from the SPR (2015). Dr. Abman has also served or led numerous study sections and workshops of the ATS, American Heart Association and NIH, as an Associate Editor for the American Journal of Respiratory and Critical Care Medicine, and on editorial boards for many leading journals.
Emmanuel Addo-Yobo is an Associate Professor of Child Health at the School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), and Honorary Consultant Paediatrician in the Child Health Directorate, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana.
Prof. Addo-Yobo is a Paediatrician, clinical lecturer, researcher and administrator with primary clinical interests in Paediatric pulmonology, Immunization practice and child survival issues. His experience in child health care in Ghana spans over 25 years. He is the Head of the Paediatric Asthma and Pulmonology Unit at KATH, which he pioneered in 1992 as one of the very few of its kind in the sub-region at the time. Out of this came a number of research studies and publications on asthma epidemiology in Ghana in collaboration the North West Lung Centre, Manchester, and the Tropical Health and Education Trust (THET) United Kingdom. He has also been involved in USAID and WHO sponsored multi-centre collaborative research on treatment options for childhood pneumonia and common young infant infections in developing countries.
Prof Addo-Yobo has also made contributions to local and WHO regional manuals for care of young children especially in the area of respiratory disorders. He has worked in collaboration with the Ministry of Health, Ghana and WHO, on many national committees on child health and development such as School Health Policy Review, Job Aids for New-born Care, Integrated Management of Childhood and Neonatal Illness (IMCNI), and Under-5 Child Health Policy for Ghana.
Prof Addo-Yobo has been involved in vaccine preventable disease surveillance activities and in developing Pre-service curricula for the Expanded Programme on Immunization (EPI) for Medical and Nursing /Midwifery Training institutions in the African Region, as well as its introduction and evaluation activities. He has assisted Ministries of Health in countries and key partner agencies to conduct Training Needs Assessments for EPI staff.
He currently Heads the Department of Child Health, School of Medical Sciences – KNUST and KATH. He is also the Head of Quality Assurance and patient safety at KATH. He is a member of the Medical and Chemicals Technical Option Committee (MCTOC) of the Technology and Economic Assessment Panel (TEAP) under the Montreal Protocol on substances that deplete the Ozone Layer.
Savvas Andronikou [MBBCh (Wits), FCRad (Diagn)(SA), FRCR (Lond), PhD (UCT), PhD (Wits)] is a pediatric radiologist and full professor at both the University of Bristol (UK) and the University of Cape Town (South Africa). He supervises multiple masters and PhD students, has authored over 200 publications, 4 books and further chapters in books. He was previously HOD of Radiology at Red Cross Children’s Hospital in Cape Town, Johannesburg Hospital and Tygerberg Hospital and he has held Chairs in Radiology at the Universities of Stellenbosch and Witwatersrand. He has received research awards from the College of Radiologists of South Africa, Stellenbosch University and University of the Witwatersrand. Other awards include scholarships of the Radiological Society of North America, the Derek Harwood Nash scholarship and Honorary Membership of the Society of Pediatric Radiology in 2013. He has served as councilor, secretary and has been president of the College of Radiologists of South Africa for two terms. He was also founding chairman of the South African Society of Pediatric Imaging and the African Society of Pediatric Imaging. He now serves as vice chair of the international committee of the Radiological Society of North America for Africa and middle East. He has been a ‘visiting professor’ at Children’s Hospital Philadelphia; Lucille Packard Children’s Hospital, Stanford; Toronto Hospital for Sick Children; Mercy Children’s Hospital, Kansas City, Columbia Medical Centre, NYC; UCSF Medical Centre, San Francisco; Black Lion Hospital, Addis Ababa; University of Pretoria and MEDUNSA. As chairman of the outreach committee of the World Federation of Pediatric Imaging he created a volunteer group of radiologists and continues to provide daily volunteer tele-reading for Medecins Sans Frontiers. He is currently consultant radiologist and full Professor at the Bristol Royal Hospital for Children and the University of Bristol.
Professor Eugenio Baraldi, MD, FCCP
Professor of Pediatrics, Women’s and Children’s Health Department, University of Padova, Italy.
Head, Unit of Neonatology and Neonatal Intensive Care, University of Padova
Past-President Italian Society for Pediatric Respiratory Diseases (SIMRI)
More than 150 scientific publications in peer review journals (including NEJM, Lancet and JAMA)
Referee for more than 10 academic and clinical journals.
Reviewer of research programs for Netherlands Asthma Foundation and The Asthma Foundation of Western Australia.
Member of Paediatric HERMES (Harmonised Education in Respiratory Medicine for European Specialists) Task Force
Member of ReSViNET an international, multidisciplinary and translational research approach focused on RSV infections.
Primary research interests : pediatric asthma, markers of airway inflammation, BPD and metabolomics.
Danielle Belgrave, PhD is a Research Fellow in Biomedical Modelling at Imperial College London.
She is the recipient of an MRC Career Development Award in Biostatistics (2015) and her research focuses on latent variable modelling for accelerated endotype discovery.
There is growing recognition that asthma is not a single disease but a collection of diseases with similar clinical presentations. Statistical machine learning modelling techniques allow us to achieve a better understanding of the underlying complexities of asthma and allergic diseases based on this observed heterogeneity in the clinical manifestations of symptoms, especially during childhood. Dr Belgrave’s work is aimed towards understanding the genetic, biological and environmental factors associated with distinct developmental profiles of asthma and allergy in order to enable more personalised treatment and management strategies.
She has been the recipient of a number of awards including the Microsoft Research PhD Programme Scholarship and the Dorothy Hodgkins Postgraduate Award (2010), the Barry Kay Award from the British Society of Allergy and Clinical Immunology (2011) and Best Presentation Awards at the European Academy of Allergy and Clinical Immunology (2010 and 2013).
She has also spent time working in respiratory medicine in the pharmaceutical industry and during this time, she received the GlaxoSmithKline Exceptional Scientist Award (2015) for her statistical methodological work.
Klaus Bønnelykke is a PHD and MD with training in pediatrics. His research is based on the COpenhagen Prospective Studies on Asthma in Childhood (COPSAC) research center where he has worked several years as a senior researcher. His research area can be described as clinical translational research combining clinical data from birth cohort studies with basic research methodologies. The focus is early origins and functional subtypes (endotypes) of asthma, allergy and eczema with a particular emphasis on genetics. This has resulted in novel discoveries of susceptibility genes and other risk factors for asthma, eczema and allergy. He has authored or co-authored more than 70 peer-reviewed articles in international medical journals.
He has been the recipient of a number of awards including the Lundbeck Foundation Fellowship (2014), the Klosterfrau Research Award for Outstanding Research in Pediatric Pulmonology (2014), the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology (2014), and a Best Presentation Award at the European Academy of Allergology and Clinical Immunology congress (2014).
Prof. Andrew Bush is the Professor of Paediatrics and Head of Section (Paediatrics), Imperial College, Professor of Paediatric Respirology, National Heart and Lung Institute, and Consultant Paediatric Chest Physician, Royal Brompton Hospital, London UK. He is also Editor in Chief of Thorax, with Professor Ian Pavord.
His main research interests are the invasive and non-invasive assessment of airway inflammation, paediatric clinical physiology, and orphan lung diseases.
Dr Carlo Castellani trained in the Pediatric Department of the University of Verona. He is registered Pediatrician and registered Medical Geneticist. In 1992 he joined the Verona Cystic Fibrosis Centre, where he is now in charge of the Clinical Genetics and Neonatal Screening Services and of the adult section.
In Italy he has served on a number of committees including the board of the Italian Cystic Fibrosis Working Group and the Commission on Patterns of Genetic Analysis for Cystic Fibrosis. He is presently President of the Italian Cystic Fibrosis Society.
His international functions include membership of the CF Diagnostic Network and participation in scientific committees of the European Cystic Fibrosis conference and North American Cystic Fibrosis conference. He has been advisor in the Subcommittee on Newborn Screening for Cystic Fibrosis of the Clinical and Laboratory Standard Institute. Dr Castellani has started and chaired the ECFS Working Group on Neonatal Screening and has been board member, secretary and vicepresident of the European Cystic Fibrosis Society. He has led several several ECFS consensus initiatives which produced guidelines on CFTR mutation analysis in clinical practice, CF neonatal screening, CF carrier screening and CF Standards of Care. Dr Castellani is a member of the CFTR2 core team.
His main clinical and research interests lie in CF epidemiology, genotype/phenotype correlation, CF diagnosis, CFTR-related disorders, neonatal screening and CF adult care. He has published in several peer reviewed jourmals, including JAMA, Nature Genet, the Lancet, Am J Respir Crit Care Med, Am J Hum Genet, Am J Med Genet, J of Pediatr, J Med Genet, Pancreatology, Acta Paediatr, Thorax, Pediatric Pulmonol, J Mol Med, Am J Gastroenterol, Am J Epidemiol, Eur Resp J, Hum Mutation, Hum Genet, Arch Dis Childhood, J Cyst Fibros and Eur J Hum Genet.
His present international research projects include the North American Cystic Fibrosis Foundation “CFTR2” project (European coordinator),
Andrew Colin, MD is the Batchelor Professor of Cystic Fibrosis and Pediatric Pulmonology and Chief of the Division of Pediatric Pulmonology, Miller School of Medicine of the University of Miami. He has continually held leadership positions with the International Congresses of Pediatric Pulmonology (CIPP) and served as the President of its 10th and 11th Congresses.
Dr. Colin published extensively and presented nationally and internationally in areas of his interest: structural and functional development and morbidity of the respiratory system with related physiological measurements, including lung diseases of late prematurity, infants with CF and HIV. Pediatric bronchoscopy. Infectious and inflammatory diseases of the lung. Pediatric Radiology.
Adnan Custovic is Clinical Professor of Paediatric Allergy at Imperial College London. His research has focused upon the origins and natural history of asthma and allergy across the life-course, with an emphasis on prevention and translation for patient benefit. His research findings are of great practical significance, and have informed and changed national and international guidelines on asthma prevention/management. His current research programme combines world-leading expertise in birth cohorts and statistical machine learning, and capitalises on the recent developments within the field of computer sciences to provide powerful new tools that are well suited to the challenge of integration of different scales of data (from molecular-level to population-level), and different levels of directness of measurement of factors.
In 2015 Prof Custovic was awarded the highly competitive European Respiratory Society Gold Medal for research in asthma. In 2013 he received the BSACI William Frankland Medal for outstanding contributions to clinical allergy, and the CIPP President’s award for the distinguished achievements in childhood asthma. He delivered numerous prestigious keynote/named lectures, including Nemacolin Asthma Conference (2014), Alain De Weck Memorial Lecture (2013), Cas Motala Memorial Lecture (South African Allergy Society, 2013), James Hutchison's Memorial Lecture (Hong Kong Paediatric Society, 2012), the RSM Priscilla Piper Lecture (2011) and Caspar Weinberg Lecture (2007).
He has served as a Secretary of the BSACI for two terms, and as President of Asthma section of the EAACI.
Renato Cutrera is Pediatrician, Pulmonologist, specialized in Phtisiology and Respiratory System diseases and in Pediatrics at the University of Rome “La Sapienza” (Italy).Chief Medical Officer of the Bronchopneumology Unit
Chief Medical Officer of Health Facility and Organization Department.
President of SIMRI (Società Italiana delle Malattie Respiratorie Infantili – Italian Society of Children’s Respiratory Diseases) and author of many scientific publications.
Prof. Pierre Goussard is a pediatric pulmonologist working at Tygerberg children`s hospital in Cape Town South Africa which acts as a referral center for complicated cases including disease like Tuberculosis , HIV, complicated pneumonia as well as complicated airway pathology and congenital lesions. Responsible for pediatric bronchoscopes. Where do about 350 cases per year which includes flexible bronchoscopes and rigid bronchoscope. We also do a large number of different interventional procedures. His research fields included airway disease due to tuberculosis as well as new diagnostic methods using BAL in tuberculosis and other disease. He has recently completed my PhD and has published 56 peer review articles and a number of book chapters.
R. Paul Guillerman is Professor of Radiology at the Baylor College of Medicine and the Department of Pediatric Radiology at Texas Children’s Hospital in Houston, Texas.
His clinical and research interests include imaging of pediatric diffuse lung diseases, chest CT technique optimization, and radiation risk assessment and communication.
He has given over 100 invited lectures, authored or co-authored over 70 medical journal articles and textbook chapters, and co-edited the latest edition of the Springer textbook Pediatric Chest Imaging.
He is co-director of the Center for Diagnostic Imaging of the Cystic Fibrosis Foundation (CFF) Therapeutic Development Network and is the Radiological Society of North America (RSNA) representative for the Alliance for Radiation Safety in Pediatric Imaging.
He is also a member of the CFF Preschool Age Screening and Monitoring Workgroup, Children’s Interstitial Lung Disease Research Network (ChILDRN), Image Gently Speakers Group, American College of Radiology (ACR) Committee on Education - Pediatrics, Society for Pediatric Radiology (SPR) CT Committee, and ACR-SCBT-MR-SPR Practice Guideline for the Performance of Thoracic CT Committee.
Prof. Eitan Kerem, MD, a world known leader in Cystic Fibrosis research, is a principal investigator of numerous national and international multicenter clinical trials. He is the author of seminal publications in the field, including phenotype-genotype relationships, disease prognostic factors, the molecular mechanisms for disease variability, and the development of novel mutation-specific pharmacological therapies to correct the basic defects in cystic fibrosis.
His many interests extend beyond cystic fibrosis, and he has been central to studies examining environmental interactions with genetic diseases and its influence on the disease severity, genetic markers of asthma and allergy in closed populations, and variability of disease in closed populations exposed to different environments. Increasingly, his efforts have turned to understanding the genetics of primary ciliary dyskinesia in Jewish and Palestinian children. In addition he published leading papers on management of community acquired pneumonia in children and was the first to characterize nectrotizing pneumonia and risk factors for complicated pneumonia in children.
The promotion of the medical, ethical and rights aspects of children with chronic diseases is at the forefront of his interest. He published many papers in this field and is known for his advocacy for children in need.
He also has a record of building bridges between Israelis and Palestinians furthering peace through medicine wherever possible.
Professor Kerem received a number of prestigious awards the last being the European CF Society Award in 2014.
He has authored over 170 papers covering all aspects of Pulmonology.
Dr Indu Khosla, a valedictorian in Pediatrics from the Mumbai University, India (1989) runs a busy paediatric care centre in the bustling metropolis of Mumbai. About half her working hours are spent caring for children with acute and chronic respiratory illness. She was a consultant at the PD Hinduja Hospital a tertiary care hospital for 8 years till recently.
In the absence of a formal training program in paediatric pulmonology in India, Indu has largely been a self-taught individual. After an incisive stint as an observer in pediatric pulmonology in 2006 at Southampton, UK with the RCPCH grant, and an Observer post at the Overlake Hospital in Seattle for sleep medicine, she trained in Bronchoscopy in India.
She has been a core team member in writing the guidelines for management of asthma for children of India (called ABC -Asthma by consensus) and its accompanying power point module (ATM-Asthma training module). Both these have been hugely successful programs of the Indian Academy of Pediatrics. She has lectured through the length and breadth of the country and has conducted various workshops for training physicians, paramedics and laypersons in Asthma management and is in the process of designing a large multi centric study for prevalence of Asthma in India. She actively works with the Respiratory chapter of the Indian Academy of Pediatrics and has recently organised a large respiratory meet in Mumbai which was attended by paediatric pulmonologists and paediatricians from India and the Asian sub-continent. She is also working on forming a Registry for PCD in India. She is part of the subcommittee for writing OSA guidelines for the Asia Pacific region.
Dr Jane Kirkby is a Highly Specialist Clinical Physiologist involved in clinical, academic and research activities. Much of her research has involved the standardisation of lung function assessments, the long term impact of lung disease in childhood and the early origins of adult lung disease.
- 1. Academic Education
2012: Completed PhD thesis entitled “Application and Interpretation of Paediatric Lung Function.” The thesis was supervised by Dr Sam Sonnappa and Prof. Janet Stocks at UCL. (Viva date: 25th June 2012).
2007: Graduate Certificate in Paediatric Respiratory Science (University of Western Australia)
- 2. Employment
April 2014 to present: Highly Specialist Respiratory Physiologist: Managing the infant and children’s lung function laboratory at Great Ormond Street Hospital for Children NHS Foundation Trust.
- 3. Research Experience
- • EPICure Study: The 11 year respiratory follow up of children born extremely pre-term (MRC-funded).
- • Asthma UK Initiative: An international collaboration of paediatric reference data.
- • SAC study: The Sleep, Sickle Cell and Asthma cohort study. NHLBI funded international longitudinal study of children with Sickle cell disease.
- • Wellcome Trust funded SLIC study (Size and Lung Function in Children). Investigated the relationship between body size and composition and lung growth in healthy children of all ethnicities.
- • Wellcome Trust funded ChroSAM study: 7 year follow-up of Malawian children admitted with severe acute malnutrition..
- • Involved in a number of collaborative initiatives including the Global Lung Function Initiative, the Health Survey for England, and the European Respiratory Society (ERS)
- • I have provided training and quality control for lung function tests for a variety of international studies
- 4. Teaching and presentations
- • Regularly lecture on MSc modules and ARTP (Association for Respiratory Technology and Physiology) lung function interpretation courses.
- • Invited to lecture at the West Country Chest Society annual meeting, the Welsh Respiratory Physiology conference and the ARTP National Strategy Meeting.
- • Set up several spirometry courses and teaching sessions within the hospital Trust and given external lectures to other hospitals (including video conference to India).
Professor Keith Klugman is the Director of Pneumonia at the Bill and Melinda Gates Foundation in Seattle WA. He is the Emeritus William H. Foege Chair of Global Health at the Hubert Department of Global Health, Emory University, Atlanta, Georgia. In addition, he serves as an Honorary Professor in the Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, in Johannesburg, South Africa.
Professor Klugman is currently the Past President of the International Society of Infectious Diseases; he is Treasurer of the Board of the International Symposium of Pneumococci and Pneumococcal Diseases; and a past Chair of the International Board of the American Society for Microbiology. In 2015 Keith was elected to membership of the US National Academy of Medicine. He has chaired or served on numerous expert committees for the World Health Organization (WHO), the Wellcome Trust and the Centers for Disease Control and Prevention (CDC). He serves as an editor or member of the editorial board of 16 journals.
Professor Klugman has made major contributions to the field of pneumococcal disease. His work, including the demonstration of pneumococcal conjugate vaccine efficacy in the developing world, has led to interventions that have saved millions of lives especially in Africa. He has published more than 500 scientific papers which have been cited more than 25,000 times to date. His current position allows him the opportunity to contribute to the mission of the Gates Foundation to reduce deaths from pneumonia in children, thus allowing them the chance to lead healthy and productive lives.
Prof. Amir Kugelman is a Clinical Associate Professor of Pediatrics in The R&B Rappaport Faculty of Medicine, Technion, Haifa, Israel. He specialized in Pediatric Pulmonology and Neonatology in Children's Hospital, LA, CA, and is currently the Director of the Pediatric Pulmonary Unit and a Senior Neonatologist in Bnai Zion Medical Center, Haifa, Israel and the Chairman of the Israeli Society of Pediatric Pulmonology.
His main research is in Neonatal Pulmonology, focusing on non- invasive ventilation, non-invasive respiratory monitoring in the NICU and the Pediatric Department, and in the prevention and treatment of Choric Lung Disease of premature infants. Other areas of interest and research: Iatrogenesis in NICUs, late preterm infants, outcome of VLBW infants, and delayed cord clamping in the delivery room.
Dr. Enrico Lombardi, MD graduated in Medicine from the University of Florence, Italy, in 1991. From 1995 to 1996 he was a research associate in Tucson, Arizona, where he worked and published in the fields of lung function testing in young children and the epidemiology of pediatric asthma. He completed his residency in Pediatrics in 1997 in Florence, where in 2001 he took a position as Pediatrician at the “Anna Meyer” Children’s Hospital. In 2006 he completed the specialization in Diseases of the Respiratory System and since then he is in charge of the Pediatric Pulmonary Unit at Meyer Children’s Hospital. Dr. Lombardi was the chair of the 7.1 Group “Paediatric Respiratory Physiology and Sleep” of the European Respiratory Society from 2012 to 2015 and chair of the International Relation Committee of the Pediatric Assembly of the American Thoracic Society from 2010 to 2016. His main area of interest is lung function testing in young children, on which he has published extensively and presented nationally and internationally.
Dr Sooky Lum is a Senior Research Fellow at the Respiratory, Critical Care and Anaesthesia department, UCL, Institute of Child Health in London. She initially trained as a nurse and midwife and in 1997, joined the infant lung function research team as a research midwife at the UCL, Institute of Child Health, London to investigate the association between low birthweight for gestation and airway function during infancy which formed the basis of her PhD thesis. Since her PhD award, she has been actively involved in the development and validation of new techniques and equipment for assessing airway function in infants and young children and is an active member of the international (ATS/ERS) taskforce in the standardisation of lung function measurements in infants and young children. Her major research interests focus on lung growth and development in both healthy infants and children as well as in those who were born extremely preterm and in children with cystic fibrosis. She is currently the principal investigator for the Wellcome Trust funded “Size and Lung function In Children” (SLIC) study to explore the associations of body size, shape and composition on ethnic differences in lung function in children (www.ucl.ac.uk/slic).
Dr. Fernando D. Martinez is a Regents’ Professor and Director of the Asthma and Airway Disease Research Center at the University of Arizona in Tucson.
Dr. Martinez is a world-renowned expert, and one of the most highly regarded researchers, in the field of childhood asthma. His primary research interests are the natural history, genetics, and treatment of childhood asthma.
His groundbreaking research has had an impact on his field in numerous ways, most prominent among them the development of the concept of the early origins of asthma and COPD. This concept is now widely accepted as the potential basis for the design of new strategies for the prevention of these devastating illnesses affecting millions of children and adults worldwide. In addition, Dr. Martinez has made important contributions to our understanding of the role of gene-environment interactions in the development of asthma and allergies. He has also been the principal investigator of one of the Clinical Centers that are part of the NHLBI Asthma Treatment Networks, which have contributed fundamental new evidence on which to base national guidelines for the treatment of the disease.
Dr. Martinez currently serves on national scientific boards including the NHLBI National Advisory Council and the National Scientific Council on the Developing Child. He was a member of the National Asthma Education and Prevention Program that was responsible for the development of the Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma in 1997 and its first revision in 2001. He also has been a member of the FDA Pulmonary-Allergy Drugs Advisory Committee and the Board of Extramural Advisors of the National Heart, Lung, and Blood Institute (NHLBI).
Dr. Martinez’s research and vision are well detailed in more than 250 original research papers and editorials, many in collaboration with investigators from all over the world. He is frequently invited to give keynote presentations at national and international meetings.
1986: Medical Doctor degree University of Catania; 1992: Specialization in Radiology University of Verona.
From october 1988 to september 2004: Clinical Staff Member in the Department of Radiology of the University of Verona. From September 2004: Chief of the Radiological Department of the Treviso General Hospital.He was habilitated for full Professorship in Radiology in 2014.Member of Italian Association of Medical Radiology, European Society of Radiology, Radiological Society of North America, European Society of Gastrointestinal Radiology, International Society for Magnetic Resonance in Medicine.He is in the Editorial Board of “Radiologia Medica” since 2006 and “Radiology of infectious diseases” (2015-2017). He is reviewer for “Radiologia Medica”, “Eurorad”, “European Radiology”, “European Journal of Radiology”, “World Journal of Hepatology”, “Cancer Imaging”, “Abdominal Imaging”. He has been involved in the Scientific Commetee of ECR from 2005 up to 2010.He has been meeting president of the 22nd annual meeting of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Venice, May 21-24, 2011.
He is President of the Regional Committee (Veneto and Trentino-Alto Adige) of the Italian Society of Radiology (SIRM), 2013-now.He has published 58 papers, 25 chapters of book, 82 abstracts and 36 posters.His posters have been prized in several international meetings (ECR 2000, ECR 2001, ESGAR 2001, ECR 2002, ICIS 2013).He has been given more than 250 lectures either in national and international meetings.
Dr. Liam O’Mahony received his BSc in Microbiology from University College Cork, Ireland in 1994 and his PhD in Immunology was awarded in 1998 by Trinity College Dublin, Ireland. Thereafter, Dr. O’Mahony performed post-doctoral research at the Department of Microbiology, University College Cork, Department of Medicine, University College Cork and the Digestive Diseases Division, UCLA. Dr. O’Mahony was a Principal Investigator at the Alimentary Pharmabiotic Centre, University College Cork, from 2003 to 2008. Since 2009, he is the head of Molecular Immunology at the Swiss Institute of Allergy and Asthma Research, University of Zürich, Switzerland. His research interests are focused on the molecular basis for microbe and metabolite modulation of mucosal inflammatory responses. He is a co-author on more than 80 published articles and is a co-inventor on 7 granted patents. Current research grants are from the Swiss National Science Fund, European Union and from industry. Dr. O’Mahony currently chairs the Immunology section board of the European Academy of Allergy and Clinical Immunology (EAACI).
Prof. Giorgio Piacentini is Functional Head of the UOS Pediatric Respiratory Disease Section, Pediatric Department AOUI Verona, Italy
1987: Medical Degree at the Universita' di Verona school of medicine with the experimetal thesis titled: “Therapy of chronic asthma in pediatrics: a possibile anti-inflammatory mechanism of theophylline”
1988: Admission to PhD in Fisiopatologia Metabolica Congenita, Universita' di Verona school of Medicine.
February 1990-March 1991: Research fellow at the "International center for Interdisciplinary Studies of Immunology" , Georgetown University di Washington, DC, USA, directed by Prof. Joseph A. Bellanti, and the "Allergy Division" ot the "National Institute of Allergy and Infectious Diseases" , Bethesda, MD, USA, directed by Dr. Anthony Fauci.
1991: Senior Research Associate of Pediatrics at the University of Verona, School of Medicine
1992: Certified PhD.
March 1993: Research stay at the "Division of Allergy and Clinical Immunology" dell'"University of Virginia", Charlottesville, VA, USA, directed by Prof. Thomas AE Platts-Mills.
1994: Board certified Pediatrician
September 2002: Associate Professor of Pediatrics at the University of Verona, School of Medicine.
December 2014: Full Professor of Pediatrics at the University of Verona, School of Medicine
Functional Head of the UOS Pediatric Respiratory Disease Section, Pediatric Department AOUI Verona, Italy
Dr. Giovanni Piedimonte is currently the Steven and Nancy Calabrese Chair for Excellence in Pediatric Care, Research, and Education and Professor & Chair of Pediatrics of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He also serves as Chairman of the Cleveland Clinic Pediatric Institute, Physician-in-Chief of the Cleveland Clinic Children’s Hospital, and President of the Cleveland Clinic Children’s Hospital for Rehabilitation in Cleveland, Ohio, U.S.A.
Dr. Piedimonte has authored or co-authored over 350 peer-reviewed journal articles, book chapters, monographs, editorials, and abstracts with the primary focus on airway inflammation in childhood respiratory disease, the role of early viral respiratory infections in the pathogenesis of asthma, and the neurobiology of the developing respiratory tract. He has been an invited speaker nationally and internationally on more than 400 occasions, and is the recipient of the 1997 Career Investigator Award of the American Lung Association, the 1999 Investigator Award of the Asthma and Allergy Foundation of America, and the 2008 Pfizer Visiting Professorship in Pulmonology. He is a fellow of both the American Academy of Pediatrics and the American College of Chest Physicians.
Dr. Piedimonte’s research has been funded by the U. S. National Institutes of Health (NIH) for more than 15 consecutive years and he has been principal investigator or co-investigator of more than 30 research projects funded by the NIH, the National Cystic Fibrosis Foundation, the American Lung Association, the Asthma and Allergy Foundation of America, and the pharmaceutical industry. He served as a regular member of the Respiratory Integrative Biology and Translational (RIBT) Research Study Section of the NIH Center for Scientific Review. He also holds 18 U.S. and international patents protecting some of his discoveries.
Christian Poets, MD, is Professor of Paediatrics at Tuebingen University. He graduated from Hannover Medical School in June 1986 and received his medical and scientific training at the Dept. of Pediatric Pulmonology & Neonatoloy, Hannover Medical School, Hannover, and at the Dept. of Paediatric Respiratory Physiology, National Heart & Lung Institute, London, UK. In 1994, he became consultant paediatrician, in charge of the Neonatal Intensive Care Unit and the Paediatric Sleep Lab in Hannover, and was appointed Head of the Department of Neonatology at Tuebingen University in 2002. In 2007, he became speaker of the newly founded Centre for Craniofacial Malformations at Tuebingen University Hospital. He also served as president of the Society for Neonatology and Paediatric Intensive Care from 2006-2010. His main research interests lie in the control of breathing, oxygen monitoring, innate immunity, neonatal clinical studies and epidemiology. Currently, he is (Co-)PI of 2 large grants to study the effects of inhaled steroids and automated oxygen control, respectively, on neurologically intact survival and BPD prevention in extremely low gestational age infants. He has co-authored >280 articles cited in PubMed and has contributed to over 120 review articles. He is a member of the Neonatal Society (London) and the German Society of Neonatology & Pediatric Intensive Care
Prof. Petr Pohunek, MD PhD FCCP. Head, Division of Pediatric Respiratory Diseases, Pediatric Department, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Chairman of the Czech Society for Pediatric Pulmonology.
Chairman, Group 7.7 (Pediatric Bronchology) of the Pediatric Assembly of the European Respiratory Society.
Main research interest: Pediatric Asthma; Primary ciliary dyskinesia; Pediatric chronic respiratory diseases.
Prof. Jean-Paul Praud is a Senior Pediatric Pulmonologist at the Sherbrooke University Hospital, Quebec, Canada, and Director, Center for Research into Maternal and Child Health, University of Sherbrooke. He holds the Canada Research Chair in Neonatal Respiratory Physiology.
He is Past-President, CIPP V and has been President, ICPP-The Course, since 2007.
His main research interests are in the field of sleep apneas, nasal ventilation and laryngeal function.
Prof. Giovanni A. Rossi
1990 - Present: Chief, Pulmonary and Allergy Units, G. Gaslini Institute, Genoa, Italy.
1992 - Present: Adjunct Professor of Paediatric Pulmonology, University of Genoa, Italy.
1980 - Present: Member of the American Thoracic Society.
1992 - 1994: Chairman of the Assembly "Lung Cell Biology" of the European Respiratory Society.
1992 - 1994: Member of the Executive Committee of the European Respiratory Society.
1999 - 2005: Assessor of the Interasma Executive Committee
2007 - 2011: President Italian Society of Paediatric Respiratory Disorders.
1985 - 1987: Associate Editor, "Bulletin Europeen de Physiopathologiae Respiratoire".
1986 - 1992: Section Editor for Immunology & Lung Cells, of "The European Respiratory Journal".
1991 - Present: Charter Member of the Board of Reviewing Editors of the "Journal of Laboratory and Clinical Medicine".
1992 - 2004: Member of the Editorial Board, "Paediatric Pulmonology".
1992 - 2005: Member of the Editorial Board, "Monaldi, Archives for Chest Diseases".
2004 - Present: Member of the editorial board of "Current Pediatric Reviews."
2004 - Present: Member of the editorial board of “Current Respiratory Medicine Reviews."
2007 - 2010: Section Editor of “Respiratory Medicine”
Major research interests:
Publications: 1 book, 14 book chapters and 283 manuscripts (pubmed).
Prof. Bruce Rubin is the Jessie Ball duPont Distinguished Professor and Chair of Pediatrics at Virginia Commonwealth University in Richmond, Virginia and Physician in Chief of the Children’s Hospital of Richmond. He is also Professor of Biomedical Engineering and Adjunct Professor of Physiology and Biophysics at VCU. Prof Rubin is a pediatric pulmonary physician and a Fellow of the Royal Society of Physicians of Canada (FRCPC). As a Rhodes Scholar, he trained as a post doc in Biomedical Engineering at Oxford University and in Paediatric Respirology at Sick Kids in Toronto. He holds the MD and Masters in Engineering degrees from Tulane and an MBA degree from Wake Forest University School of Business.
Dr. Rubin received the 2008 Forrest M. Bird Lifetime Scientific Achievement Award, the top research honor given by the American Association for Respiratory Care (AARC), in 2011 he presented the Phil Kittredge Memorial Keynote lecture at the AARC in 2012, he was awarded Jimmy Young Memorial medal from the AARC. He holds honorary appointments in 4 medical schools. He is on the editorial board of 12 medical journals, has published more than 200 original research papers and chapters and holds seven patents. Dr. Rubin and his research team study aerosol therapy for lung diseases, airway inflammation and excessive mucus that contributes to lung disease.
He is also an accomplished magician, an elected member of the International Brotherhood of Magicians, and over the past 20 years had taught medical magic in 28 countries on 5 continents.
Sejal Saglani is Reader in Paediatric Respiratory Medicine at the National Heart & Lung Institute, Imperial College London and Honorary Consultant in Respiratory Paediatrics, Royal Brompton Hospital, London.
The focus of her research includes: 1) mechanisms underlying the development of wheezing disorders in preschool children and factors that determine progression to childhood asthma, and management of preschool wheezing using inflammatory and infective airway phenotypes. 2) Diagnosis and management of paediatric severe therapy resistant asthma and mechanisms mediating the pathophysiology of severe disease to determine novel therapeutic targets.
She runs a translational research programme incorporating a neonatal murine model of inhaled allergen exposure and bronchoscopic airway samples from children with severe wheezing and asthma.
Francesca Santamaria is Associate Professor of Pediatrics, Department of Translational Medical Sciences, Pediatric Section, Federico II University, Naples, Italy.
After a post-doc training on chronic pulmonary disorders (primary ciliary dyskinesia, cystic fibrosis, non-cystic fibrosis bronchiectasis, asthma), she played a leading role in the start-up and organization of the Cystic Fibrosis center and of the Pediatric Respiratory Diseases Unit, Federico II University, Naples.
She designed and coordinated several studies on:
a) primary ciliary dyskinesia, including nasal nitric oxide measurement, light and electron microscopy evaluation, chest CT and MRI comparison, cardiopulmonary assessment, sleep disturbances, growth and lung function progression;
b) cystic fibrosis gastrointestinal, nutritional, respiratory aspects, as well as genetics;
c) non CF bronchiectasis
d) pulmonary assessment in other non-pulmonary disorders, e.g. inborn errors of metabolism; obesity; primary immune defects; inflammatory bowel disorders; liver diseases; gastroesophageal reflux;
e) preschool wheezing.
She is Deputy Editor of the Italian Journal of Pediatrics, the official journal of the Italian Society of Pediatrics, and a member of the Editorial Board of Pediatric Pulmonology.
Isabelle Sermet-Gaudelus is a professor in Paediatric at the Necker-Enfants Malades Hospital, Paris France.
She graduated from the University Paul Sabatier, Toulouse in 1989 and undertook clinical trainings in Paediatrics in Paris, Assistanec Publique Hopitaux de Paris. She became involved in Cystic Fibrosis during her fellowship under the supervision of Pr G Lenoir.
She is now the head of the paediatric Cystic Fibrosis center, at the Necker-Enfants Malades Hospital.
She has been engaged for several years in a programme of phenotype-genotype studies, using epithelial electrophysiological measurements (nasal potential difference, intestinal current measurement and more recently evaporimetry).
She works closely on a number of commercially-sponsored clinical trials in CF, largely involving novel small-molecules directed at CFTR function.
She runs a clinic which accepts referrals from throughout France for questionable diagnosis for CF.
She is involved in the European Clinical Trial Network as head of the standardization committee.
She also works closely with Aleksander Edelman laboratory where she completed her phD.
She has been engaged in new CFTR corrector design, studies in the murine animal model and is now co-heading with Aleksander Edelman the group.
Florian Singer, MD PhD, is a paediatric pulmonologist and postdoctoral research fellow at the Division of Paediatric Pulmonology, University Children’s Hospital Zurich and Bern, Switzerland.
His research interests are paediatric clinical physiology and biomarkers of airway infection and inflammation. Current projects focus on the assessment of peripheral airway function and airborne metabolites.
Professor Peter Sly is the Deputy Director, Queensland Children's Medical Research Institute, Director, Children's Health and Environment Program and Director, WHO Collaborating Centre for Children's Health and Environment. Professor Sly is a NHMRC Senior Principal Research Fellow and a paediatric respiratory physician with extensive research experience in respiratory physiology, developmental immunology and children's environmental health. Professor Sly’s research aims to understand the mechanisms underlying chronic childhood lung diseases in order to improve clinical management and to delay or prevent their onset, with consequent reductions in adult lung diseases. A combination of basic science, longitudinal cohort studies and translation of research findings into clinical practice, including clinical trials, are included in three main areas: asthma, cystic fibrosis and children’s environmental health
Dr. Manuel E. Soto-Martínez is an Assistant Professor of Paediatrics and Paediatric Pulmonology, School of Medicine of the University of Costa Rica. Graduated in Paediatrics from the University of Costa Rica in 2007. From 2007 to 2010 he completed his fellowship in respiratory medicine at the Royal Children´s Hospital in Melbourne, Victoria, Australia. In addition, he completed his Masters in Epidemiology at the National University of Costa Rica (2013-2015). He is currently a Paediatric Respiratory Physician and Sleep Physician at the Respiratory Department, Hospital Nacional de Niños, San José, Costa Rica.
His areas of expertise/research:
- - Paediatric Ashtma: severe asthma, asthma epidemiology
- - Respiratory infections
- - Paediatric bronchoscopy
- - Cystic Fibrosis
- - Non-Invasive ventilation, home oxygen
- - Respiratory related Sleep Disturbances
- - Respiratory Complications in Neuromuscular disease
- - Member of the American Thoracic Society
- - Member of the European Respiratory Society
- - Member of Asociación Latinoamericana de Tórax (ALAT)
- - Member of Asociación Costarricense de Tórax
- - Consultant in Respiratory Medicine, Hospital Nacional de Niños, San José, Costa Rica
- - Coordinator Home Ventilation Program, Hospital Nacional de Niños, San José, Costa Rica.
- - A/Prof. Pediatrics, School of Medicine, Universidad de Costa Rica
- - Member of the Postgraduate in Paediatrics’ Academic Committee, Universidad de Costa Rica
Renato T. Stein, MD, MPH, PhD graduated in Medicine in 1979 from Pontifícia Universidade Católica, in Porto Alegre, Brazil where he completed his residency in Pediatrics in 1982. He took over as Assistant Professor at the Department of Pediatrics in 1986, and from 1987 to 1989 was a fellow in the Pediatric Pulmonary Service in Toronto, at The Hospital for Sick Children. In 1994 Dr. Stein took a position as a research fellow in Tucson, Arizona, where he worked with the Children’s Respiratory Study cohort, publishing in the field of risk factors related to asthma in children. In 2011 he did a 6 months sabaticcal in the Center for Environmental Epidemiology, in Barcelona, Spain. In Brazil Dr. Stein has been leading a large and productive group of researchers at his Institution. His main areas of interest are the relation between respiratory viruses and recurrent wheeze, asthma phenotypes, impact of the environment on respiratory health, and respiratory disease of preterm infants.
Alexander Ocampo Tuazon, MD, MDE. Philippine Board certified in Pediatrics and Pediatric Pulmonology, active in teaching, research and clinical practice. A holder of a Master in Distance Education. Professor in Pediatrics, past Director of the Institute of Child Health and Human Development, University of the Philippines Manila. Current Head, Section of Pediatric Pulmonology at the College of Medicine, University of the Philippines Manila, Vice President of the Philippine Pediatric Society and Member of the Philippine Subspecialty Board in Pediatric Pulmonology. Research interests include asthma, pulmonary infections and pulmonary physiology. Has published with book chapters, consensus statements on asthma, and research articles both in the Philippines and in international publications. An officer and member in a number of professional organizations involved in pediatrics, pediatric pulmonology, asthma, pharmacology, and pharmaceutical medicine. Contact Address: Section of Pulmonology, Department of Pediatrics, Philippine General Hospital, Taft Avenue, Manila, Philippines.
Prof Mariapia Villa is a Professor of Pediatrics. Head of Department of Pediatrics and Sleep Center, University “Sapienza”, faculty of medicine, Sant’Andrea Hospital, Rome.
She has carried out research about sleep-disordered breathing in children, pediatric pulmonology and allergy, pediatric neurology, continuously from 1976 to today, as evidenced by her international scientific production. She has produced numerous scientific papers on prestigious international journals: 143 published articles, HI = 22 (http://www.ncbi.nlm.nih.gov/pubmed/?term=villa+mp).
Dr. T.F. Yeh was born in Taiwan. Following his medical education in Taiwan, he went to United States and completed pediatrics and pediatric neonatology training at Cook County Children’s Hospital and University of Illinois Hospital in Chicago. Dr. Yeh subsequently joined the faculty in the Department of Pediatrics, College of Medicine, University of Illinois in Chicago. He became professor of pediatrics, University of Illinois and director of NICU at Cook County Children’s Hospital in 1985. In 1991, Dr. Yeh moved back to Taiwan and took the position as chairman of pediatrics and vice president of the National Cheng Kung University Hospital, in charge of medical education and research. In 1992 he was granted a Ph.D. of Medical Science from National Nagasaki Medical University in Japan. In 1998, Dr. Yeh became the president of the National Cheng-Kung University Hospital in Taiwan. The hospital has 1500 beds, 30 departments and 350 faculty members. In Feb 2003, Dr. Yeh was appointed as President of the China Medical University, Taichung, Taiwan, the largest medical university in Taiwan. In 2006 Dr. Yeh retired from the presidency of the university and currently is an Endowed Chaired Professor of pediatrics at both the China Medical University and Taipei Medical University..
In the past 20 years, Dr. Yeh had played a major role in the development of academic pediatrics in Taiwan. He is the founder of the Society of Neonatology and Society of Pediatrics Pulmonology in Taiwan and currently is serving as honorable president of both societies. He was the president of Taiwan Pediatric Association in 1999-2002. He was the Asian representative at large of International Congress of Pediatric Pulmonology and the consultant for many international pediatrics organizations. He is a member of Society of Pediatrics Research (SPR) and an honorary member of American Pediatric Society (APS) in U.S.A. He is an honorable Professor in many Chinese and Japanese universities. He was awarded as Best Pediatrician in Asia by Asian Congress of Pediatrics in 2000.
Dr. Yeh has published more than 200 research papers and many chapters in the peer-review journals and books, most of them in United States. He has edited two books, “Drug therapy in neonates and small infant” and “Neonatal Therapeutics” published by Year-book and Mosby Publisher.. Among his research, Dr. Yeh has focused, in the earlier days, on pharmacological closure of Patent Ductus Ateriosus and on energy balance and temperature regulation, and in the past 15 years, on strategies of prevention of Bronchopulmonary dysplasia (BPD) in premature infant, particularly in the use of glucocorticoids for prevention of BPD. His recent research using a new therapeutic regimen for prevention of BPD is worldwide recognized
Heather Zar is Professor and Chair of the Department of Paediatrics and Child Health, Director of the School of Child and Adolescent Health at Red Cross Childrens Hospital at the University of Cape Town (UCT), South Africa. After specialising in Paediatrics she did a fellowship in Paediatric Pulmonology, then a PhD. She is based at Red Cross Childrens Hospital, one of the largest dedicated childrens’ hospital in Africa. She leads a large department in providing care for sick children, training of undergraduate and post graduate students, undertaking research and advocacy to promote child health. Her work on childhood respiratory diseases, including tuberculosis, pneumonia, asthma and HIV-associated lung diseases has been internationally recognized; she has published more than 200 peer reviewed publications and has substantial international grant support. She has established a strong training program in childhood lung diseases including training several paediatricians in Africa. She currently serves as President of the Pan African Thoracic Society and President of the Forum of International Respiratory Societies. She received the World Lung Health award in 2014.